Complications After Dual Placement of a Baclofen Pump and Ventricular Shunt in Individuals With Severe Brain Injury.
Autor: | Pucks-Faes E; Department of Neurology, Hochzirl Hospital, Zirl, Austria., Dobesberger J; Department of Neurology, Paracelsus Medical University, Salzburg, Austria.; Rehabilitation Center Großgmain, Großgmain, Austria., Halbmayer LM; Department of Neurology, Hochzirl Hospital, Zirl, Austria., Hitzenberger G; Department of Neurology, Hochzirl Hospital, Zirl, Austria., Matzak H; Department of Neurology, Hochzirl Hospital, Zirl, Austria., Saltuari L; Department of Neurology, Hochzirl Hospital, Zirl, Austria.; Research Unit for Neurorehabilitation in South Tyrol, Sterzing Hospital, Sterzing, Italy. |
---|---|
Jazyk: | angličtina |
Zdroj: | Archives of rehabilitation research and clinical translation [Arch Rehabil Res Clin Transl] 2020 Sep 16; Vol. 2 (4), pp. 100082. Date of Electronic Publication: 2020 Sep 16 (Print Publication: 2020). |
DOI: | 10.1016/j.arrct.2020.100082 |
Abstrakt: | Objective: To assess the complications of dual placement of an intrathecal baclofen (ITB) pump and a ventriculoperitoneal shunt (VPS) in people with severe brain injury. Design: Case series. Setting: Referral center, ambulatory, and hospitalized care. Participants: Referred sample (N=9) composed of 5 men and 4 women with severe brain injuries (5 traumatic brain injuries, 3 subarachnoid hemorrhages, 1 intracerebral hemorrhage) and a mean disease duration of 6±4.5 years (range, 0.5-11.4y). Intervention: Both systems (ie, an ITB device and a VPS system) were implanted in all participants. Main Outcome Measures: We assessed the number and type of complications that occurred after implantation of the second system, as well as subsequent interventions. Results: The ITB delivery system was implanted after the VPS system in 5 patients (ITB group), and the VPS system was the second implanted system in 4 groups (VPS group). Seven complications occurred in 7 patients after implantation of the second system, 4 in the ITB group and 3 in the VPS group. Three of the complications were drug-related, 2 were procedure-related, and 2 were device-related. The complication occurred within 4 days after implantation of the second system in 6 patients. Conclusions: Complications are frequent in patients who undergo implantation of both an ITB delivery device and a VPS system. Drug-related complications were more common. Complications occurred more often when an ITB device was implanted as the second system. The critical period is the first 4 days. (© 2020 The Authors.) |
Databáze: | MEDLINE |
Externí odkaz: |